Skip to main content
Erschienen in: CME 3/2024

11.03.2024 | Ambulant erworbene Pneumonie | CME Fortbildung

Ambulant erworbene Pneumonie

Leitlinien-Empfehlungen zu Diagnose und Therapie

verfasst von: PD Dr. med. Matthias Wolfgang Andreas Angstwurm

Erschienen in: CME | Ausgabe 3/2024

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Sterblichkeit von Patientinnen und Patienten mit ambulant erworbener Pneumonie ist nach wie vor hoch, auch wenn die Erkrankung zunehmend gemäß Leitlinien behandelt wird. Welches die häufigsten Erreger sind, was bei der Diagnose zu beachten ist und welche therapeutischen Optionen zur Verfügung stehen, wird in diesem Beitrag erläutert. Berücksichtigung fanden dabei die aktuellen Empfehlungen der S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) sowie neue Studiendaten.
Literatur
1.
Zurück zum Zitat Theilacker C, Sprenger R, Leverkus F et al. Population-based incidence and mortality of community-acquired pneumonia in Germany. PLoS One. 2021;16:e0253118 Theilacker C, Sprenger R, Leverkus F et al. Population-based incidence and mortality of community-acquired pneumonia in Germany. PLoS One. 2021;16:e0253118
2.
Zurück zum Zitat Ewig S. The pneumonia triad. Eur Respir Mon. 2014;63:13-24 Ewig S. The pneumonia triad. Eur Respir Mon. 2014;63:13-24
3.
Zurück zum Zitat S3-Leitlinie „Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie“, AWMF Nr. 020-020, Version 30.04.2021 S3-Leitlinie „Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie“, AWMF Nr. 020-020, Version 30.04.2021
4.
Zurück zum Zitat Pletz MW, Rohde G, Schutte H et al. Epidemiology and aetiology of community-acquired pneumonia (CAP). Dtsch Med Wochenschr 2011;136:775-778 Pletz MW, Rohde G, Schutte H et al. Epidemiology and aetiology of community-acquired pneumonia (CAP). Dtsch Med Wochenschr 2011;136:775-778
5.
Zurück zum Zitat Remschmidt C, Harder T, Wichmann O et al. Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review. BMC Infect Dis. 2016;16(1):711 Remschmidt C, Harder T, Wichmann O et al. Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review. BMC Infect Dis. 2016;16(1):711
6.
Zurück zum Zitat Metlay JP, Schulz R, Li YH et al. Influence of age on symptoms at presentation in patients with community acqueired pneumonia. Arch Intern Med. 1997;157:1453-1459 Metlay JP, Schulz R, Li YH et al. Influence of age on symptoms at presentation in patients with community acqueired pneumonia. Arch Intern Med. 1997;157:1453-1459
7.
Zurück zum Zitat Ebell MH, Chupp H, Cai X et al. Accuracy of Signs and Symptoms for the Diagnosis of Community- acquired Pneumonia: A Meta-analysis. Acad Emerg Med. 2020;27:541-553 Ebell MH, Chupp H, Cai X et al. Accuracy of Signs and Symptoms for the Diagnosis of Community- acquired Pneumonia: A Meta-analysis. Acad Emerg Med. 2020;27:541-553
8.
Zurück zum Zitat Snow et al. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Int Med. 2001;134:518-520 Snow et al. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Int Med. 2001;134:518-520
9.
Zurück zum Zitat Speets AM, Hoes AW, van der Graaf Y et al. Chest radiography and pneumonia in primary care: diagnostic yield and consequences for patient management. Eur Respir J. 2006;28:933-938 Speets AM, Hoes AW, van der Graaf Y et al. Chest radiography and pneumonia in primary care: diagnostic yield and consequences for patient management. Eur Respir J. 2006;28:933-938
10.
Zurück zum Zitat Bewick T, Greenwood S, Lim WS. The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia. Clin Med. 2010;10:563-567 Bewick T, Greenwood S, Lim WS. The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia. Clin Med. 2010;10:563-567
11.
Zurück zum Zitat Hagaman JT, Rouan GW, Shipley RT et al. Admission chest radiograph lacks sensitivity in the diagnosis of community-acquired pneumonia. Am J Med Sci. 2009;337:236-240 Hagaman JT, Rouan GW, Shipley RT et al. Admission chest radiograph lacks sensitivity in the diagnosis of community-acquired pneumonia. Am J Med Sci. 2009;337:236-240
12.
Zurück zum Zitat Melbye H, Dale K. Interobserver variability in the radiographic diagnosis of adult outpatient pneumonia. Acta Radiol. 1992;33:79-81 Melbye H, Dale K. Interobserver variability in the radiographic diagnosis of adult outpatient pneumonia. Acta Radiol. 1992;33:79-81
13.
Zurück zum Zitat Young M, Marrie TJ. Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia. Arch Intern Med. 1994;154:2729-2732 Young M, Marrie TJ. Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia. Arch Intern Med. 1994;154:2729-2732
14.
Zurück zum Zitat Kitazawa T, Yoshihara H, Seo K et al. Characteristics of pneumonia with negative chest radiography in cases confirmed by computed tomography. J Community Hosp Intern Med Perspect. 2020;10:19-24 Kitazawa T, Yoshihara H, Seo K et al. Characteristics of pneumonia with negative chest radiography in cases confirmed by computed tomography. J Community Hosp Intern Med Perspect. 2020;10:19-24
15.
Zurück zum Zitat Demi L, Wolfram F, Klersy C et al. New International Guidelines and Consensus on the Use of Lung Ultrasound. J Ultrasound Med. 2023;42:309-344 Demi L, Wolfram F, Klersy C et al. New International Guidelines and Consensus on the Use of Lung Ultrasound. J Ultrasound Med. 2023;42:309-344
16.
Zurück zum Zitat Bardakci O, Daş M, Akdur G et al. Point-of-care Lung Ultrasound, Lung CT and NEWS to Predict Adverse Outcomes and Mortality in COVID-19 Associated Pneumonia. J Intensive Care Med. 2022;37(12):1614-1624 Bardakci O, Daş M, Akdur G et al. Point-of-care Lung Ultrasound, Lung CT and NEWS to Predict Adverse Outcomes and Mortality in COVID-19 Associated Pneumonia. J Intensive Care Med. 2022;37(12):1614-1624
17.
Zurück zum Zitat Syrjälä H, Broas M, Suramo I et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis. 1998;27:358-363 Syrjälä H, Broas M, Suramo I et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis. 1998;27:358-363
18.
Zurück zum Zitat Reyes LF, Bastidas AR, Quintero ET et al. Performance of the CORB (Confusion, Oxygenation, Respiratory Rate, and Blood Pressure) Scale for the Prediction of Clinical Outcomes in Pneumonia. Can Respir J. 2022; 2022: 4493777 Reyes LF, Bastidas AR, Quintero ET et al. Performance of the CORB (Confusion, Oxygenation, Respiratory Rate, and Blood Pressure) Scale for the Prediction of Clinical Outcomes in Pneumonia. Can Respir J. 2022; 2022: 4493777
19.
Zurück zum Zitat Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie. 2010;65:631-640 Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie. 2010;65:631-640
20.
Zurück zum Zitat Goldstein LH, Gabin A, Fawaz A et al. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia. Pharmacoepidemiol Drug Saf. 2015;24:1042-1048 Goldstein LH, Gabin A, Fawaz A et al. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia. Pharmacoepidemiol Drug Saf. 2015;24:1042-1048
21.
Zurück zum Zitat Blumenthal KG, Peter JG, Trubiano JA et al. Antibiotic allergy. Lancet. 2019;393:183-198 Blumenthal KG, Peter JG, Trubiano JA et al. Antibiotic allergy. Lancet. 2019;393:183-198
22.
Zurück zum Zitat Trubiano JA et al. Development and Validation of a Penicillin Allergy Clinical Decision Rule. JAMA Intern Med. 2020;180(5):1-9 Trubiano JA et al. Development and Validation of a Penicillin Allergy Clinical Decision Rule. JAMA Intern Med. 2020;180(5):1-9
23.
Zurück zum Zitat Copaescu AM et al. Efficacy of a Clinical Decision Rule to Enable Direct oral challenge in patients with low-risk Penicillin Allerhy: The PALACE randomized clinical trial. JAMA Intern Med. 2023;e232986 Copaescu AM et al. Efficacy of a Clinical Decision Rule to Enable Direct oral challenge in patients with low-risk Penicillin Allerhy: The PALACE randomized clinical trial. JAMA Intern Med. 2023;e232986
24.
Zurück zum Zitat Deshpande A, Klompas M, Guo N et al. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2023;77(2):174-185 Deshpande A, Klompas M, Guo N et al. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2023;77(2):174-185
25.
Zurück zum Zitat Dequin PF, Meziani F, Quenot JP et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931-1941 Dequin PF, Meziani F, Quenot JP et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931-1941
Metadaten
Titel
Ambulant erworbene Pneumonie
Leitlinien-Empfehlungen zu Diagnose und Therapie
verfasst von
PD Dr. med. Matthias Wolfgang Andreas Angstwurm
Publikationsdatum
11.03.2024
Verlag
Springer Medizin
Erschienen in
CME / Ausgabe 3/2024
Print ISSN: 1614-371X
Elektronische ISSN: 1614-3744
DOI
https://doi.org/10.1007/s11298-024-3799-6

Weitere Artikel der Ausgabe 3/2024

CME 3/2024 Zur Ausgabe

Therapie aktuell

Pflichtleistung der GKV